Nanomedicine for Neurodegenerative Disorders

Rishabha Malviya, PhD, is Associate Professor of Pharmacy at the School of Medical and Allied Sciences at Galgotias University, Uttar Pradesh, India. He has authored more than 150 research and review papers for national and international journals of repute. He holds over 50 patents and has edited 13 books and authored 15 book chapters. His name has been included in the World's Top 2% Scientists list by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member of more than 50 national and international journals.Kamla Pathak, PhD, is Dean and Professor of Pharmacy at Uttar Pradesh University of Medical Sciences, Etawah, India. With teaching and research experience of more than 30 years, she has received many awards for her work. She has over 270 publications in journals of international and national repute. She also holds three patents and has authored four books and more than 20 book chapters. Professor Pathak has served as a member of the editorial advisory board of AAPS Pharm Sci Tech and is also a member of various professional bodies. She is also associated with the Indian pharmaceutical industry in the capacity of a scientific consultant. She has been listed in the top 2% of Indian scientists of the subsection Pharmacology and Pharmacy, in the World's Top 2% Scientists list.Swati Verma, MPharm, is working in the Department of Pharmacy at the School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh, India. Her areas of interest are in computer-aided drug design, analytical chemistry, targeted drug delivery, and nanoformulation. She has authored four book chapters, edited two books, and many review papers published in international journals. She completed a BPharm at Dr. A.P.J. Abdul Kalam Technical University and MPharm (Pharmaceutical Chemistry) at Banasthali Vidyapith, Rajasthan, India. Her PhD work is in neurodisorders.

• 1. Neurodegenerative Disorders: Concepts, Types, and Treatment Strategies 2. Overview of the Blood-Brain Barrier (BBB) Transport Mechanisms 3. Nanodiamonds as Emerging Nanotherapeutics for Brain-Targeted Drug Delivery in the Management and Diagnosis of Neurodegenerative Disorders 4. The Real Issue in Targeting Neurodegenerative Disease 5. Strategies to Cross the Blood-Brain Barrier 6. Nanotechnology-Based Drug Delivery Systems for the Treatment of Neurodegenerative Disorders 7. Nano Approaches Towards CNS Drug Delivery 8. Current Trends in Drug-Nano Formulations Directed to the Brain 9. Selection of an Appropriate Technique for Nano-Carrier Preparation: A Multi-Criteria Decision-Making Methodology 10. Delivery of RNA/DNA to the Brain Using Nanoscience 11. Application of Medicinal Plants and Their Phytoconstituents Used in the Management of Neurodegenerative Diseases 12. Molecular Mechanisms Underpinning Neuroprotection of Nutritional Polyphenols 13. Implication of Herbal Nano-Formulations in the Treatment of Neurological Disorders 14. Medical Laboratory Diagnosis of Neurodegenerative Diseases Toward Adequate Treatment in Nanomedicine 15. Role of Biomarkers in Detection, Diagnosis, and Prognosis of Neurodegenerative Disorders 16. Use of Nano-Formulations in the Treatment of Neurodegenerative Disorders 17. Nanostructured Drug Carriers for Nose-to-Brain Drug Delivery in the Treatment of Neurological Disorders

“This book will be helpful for healthcare professionals in treating neurodegenerative disorders. It will givereaders profound insights into the recent uses of several cutting-edge nanocarriers that contain activepharmaceutical ingredients for the effective treatment of illnesses connected to neurons.”—From the Foreword by Dr. Brahmeshwar Mishra, Professor and Former Head, Department ofPharmaceutical Engineering and Technology, IIT, Uttar Pradesh, India“4 stars / score: 91. Provides an informative overview of the cutting-edge applications of various nanocarriers that encapsulate active compounds to effectively treat NDs. . . . This book is genuinely forward-thinking in the field of nanomedicine and neurodegenerative diseases. It is a high-quality resource for healthcare practitioners and scientists in drug research and development that serves as a detailed reference as well as a look into the future of therapies for neurodegenerative and similar disorders. I absolutely recommend this book in academic settings, for researchers pursuing neuropharmacology or nanotherapeutics drug design and development, and for clinicians who want a deeper understanding of where treatment innovation is heading.”—Doody’s Review Service (DRS), Jan 2026; reviewed by Chidinma Onukogu, PharmD, BCACP (Department of Veterans Affairs, USA)